Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4k6z | 1Q3 | Tyrosine-protein kinase JAK1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4k6z | 1Q3 | Tyrosine-protein kinase JAK1 | / | 1.000 | |
4e20 | 0MY | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.598 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.585 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.584 | |
4ei4 | 0Q2 | Tyrosine-protein kinase JAK1 | / | 0.582 | |
4ivd | 15T | Tyrosine-protein kinase JAK1 | / | 0.581 | |
3lxp | IZA | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.578 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.574 | |
4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.573 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.572 | |
4ivc | 1J6 | Tyrosine-protein kinase JAK1 | / | 0.570 | |
4k77 | 1Q4 | Tyrosine-protein kinase JAK1 | / | 0.570 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.567 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.562 | |
4fks | 46K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.560 | |
4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.559 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.559 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.556 | |
4acm | 7YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.552 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.551 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.550 | |
3eyh | IZA | Tyrosine-protein kinase JAK1 | / | 0.549 | |
2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.548 | |
4e1z | 0MX | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.547 | |
4ewh | T77 | Activated CDC42 kinase 1 | / | 0.546 | |
1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.545 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.545 | |
4e4l | 0NH | Tyrosine-protein kinase JAK1 | / | 0.545 | |
4idt | T28 | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.544 | |
2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.543 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.542 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.541 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.540 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.540 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.538 | |
1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.536 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.535 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.535 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.534 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.533 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.533 | |
2bkz | SBC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.532 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.532 | |
4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.532 | |
1y91 | CT9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.531 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.531 | |
2c6t | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.530 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.529 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.528 | |
4e5w | 0NT | Tyrosine-protein kinase JAK1 | / | 0.528 | |
4e6d | 0NU | Tyrosine-protein kinase JAK2 | / | 0.528 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.528 | |
4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.528 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.527 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.527 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.527 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.527 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.527 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.525 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.525 | |
2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.524 | |
4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.523 | |
4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.523 | |
3lxk | MI1 | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.522 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.522 | |
4dea | NHI | Aurora kinase A | 2.7.11.1 | 0.522 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
2vtj | LZ4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.521 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
3rpv | 26Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.521 | |
1vyz | N5B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.520 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.520 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.520 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.520 | |
1mq4 | ADP | Aurora kinase A | 2.7.11.1 | 0.519 | |
1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.519 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.519 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.519 | |
1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.518 | |
2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.518 | |
4ez3 | 0S0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.518 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.518 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.517 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.517 | |
3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.516 | |
1ol7 | ADP | Aurora kinase A | 2.7.11.1 | 0.515 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
3r73 | X87 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.515 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.515 | |
1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.514 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.514 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.513 | |
3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.513 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.513 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.513 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.513 | |
2w1g | L0G | Aurora kinase A | 2.7.11.1 | 0.512 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.512 | |
1ke9 | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.511 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.511 | |
3unk | 0BY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.511 | |
4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.511 | |
1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.510 | |
2xmy | CDK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
3s0o | 50Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
3w55 | 1FM | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.510 | |
4ehz | JAK | Tyrosine-protein kinase JAK1 | / | 0.510 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.509 | |
2c5n | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.509 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.509 | |
2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.509 | |
3qzg | X67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.509 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.509 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.508 | |
2xnb | Y8L | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.508 | |
4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.508 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.508 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.507 | |
1pxl | CK4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.507 | |
2xng | A0H | Aurora kinase A | 2.7.11.1 | 0.507 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.507 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.507 | |
1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.506 | |
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.506 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.506 | |
3r71 | X86 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.506 | |
3r9o | Z71 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.506 | |
4iva | 1J5 | Tyrosine-protein kinase JAK2 | / | 0.506 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.506 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.505 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.505 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
3mtl | FEF | Cyclin-dependent kinase 16 | 2.7.11.22 | 0.505 | |
3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.505 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.505 | |
1pxk | CK3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.504 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.504 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.504 | |
3r6x | X84 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.504 | |
3w16 | P9J | Aurora kinase A | 2.7.11.1 | 0.504 | |
4ek8 | 16K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.503 | |
4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.503 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.502 | |
3nlb | 5BE | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.502 | |
3qxo | X65 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.502 | |
5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.502 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.501 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.501 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.501 | |
5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.501 | |
1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.500 | |
4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.500 | |
4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.500 | |
1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.499 | |
2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.499 | |
2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.499 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.499 | |
3rjc | 06Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.499 | |
4fko | 20K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.499 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.499 | |
4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.499 | |
2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
2c5y | MTW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
2euf | LQQ | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.498 | |
2w1d | L0D | Aurora kinase A | 2.7.11.1 | 0.498 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.498 | |
3bht | MFR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
3roy | 22Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
3uo5 | 0BX | Aurora kinase A | 2.7.11.1 | 0.498 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.498 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.498 | |
4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.497 | |
3qtu | X44 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.497 | |
4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.497 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.496 | |
3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.496 | |
3sw4 | 18K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.496 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.496 | |
2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.495 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.495 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.495 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.495 | |
4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.495 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.494 | |
2wgj | VGH | Hepatocyte growth factor receptor | 2.7.10.1 | 0.494 | |
3fz1 | B98 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.494 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.494 | |
4eos | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
5dr2 | ATP | Aurora kinase A | 2.7.11.1 | 0.494 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.493 | |
1r78 | FMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.493 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.493 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.493 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.493 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.493 | |
4fkq | 42K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.493 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.493 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
3r1s | X73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
4eoi | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.492 | |
5buk | FAD | FADH2-dependent halogenase | / | 0.492 | |
5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.492 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.491 | |
1urw | I1P | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.491 | |
3ti1 | B49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.491 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.491 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.491 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.491 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.491 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.490 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
3qtz | X42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
3r1q | X75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
3w8q | AGS | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.490 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.490 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.490 | |
4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.490 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.490 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
2vtn | LZ7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.489 | |
3qqg | X06 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.489 | |
3rk9 | 09Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.489 | |
4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.488 | |
2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.488 | |
2qkr | IXM | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.488 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.488 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.488 | |
3qqf | X07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
3s00 | Z60 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.488 | |
4eom | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.488 | |
1oiq | HDU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
2c6i | DT1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
2eva | ADN | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.487 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.487 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.487 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.487 | |
2vti | LZ3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
2xne | ASH | Aurora kinase A | 2.7.11.1 | 0.487 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.487 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.487 | |
3ork | AGS | Serine/threonine protein kinase | / | 0.487 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.487 | |
1pye | PM1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.486 | |
2uzo | C62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
2w06 | FRV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.486 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.486 | |
4fk6 | 0UJ | Tyrosine-protein kinase JAK1 | / | 0.486 | |
4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.486 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.485 | |
3nbw | TR4 | Ketohexokinase | / | 0.485 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.485 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.485 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.485 | |
4mwh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.485 | |
5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.485 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.484 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.484 | |
2pml | ANP | Uncharacterized protein | / | 0.484 | |
2vth | LZ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.484 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.484 | |
3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.484 | |
3zls | 92P | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.484 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.484 | |
2hck | QUE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.483 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.483 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.483 | |
4c3r | ACP | Aurora kinase A | 2.7.11.1 | 0.483 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.483 | |
4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.483 | |
1e1x | NW1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.482 | |
1rfu | ADP | Pyridoxal kinase | 2.7.1.35 | 0.482 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
2r3i | SCF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.482 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.482 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.482 | |
3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.482 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.482 | |
4fkj | 11K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
1ke8 | LS4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
1v1k | 3FP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2jko | BIJ | Focal adhesion kinase 1 | 2.7.10.2 | 0.481 | |
2wmr | ZYR | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
3kc3 | MK2 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.481 | |
3lq5 | SLQ | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.481 | |
3qzh | X69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3r7e | X88 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.481 | |
4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.481 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.480 | |
2r3l | SCW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
2vag | V25 | Dual specificity protein kinase CLK1 | 2.7.12.1 | 0.480 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.480 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.480 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
3rm7 | 19Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.480 | |
4fi1 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.480 | |
4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.480 | |
1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.479 | |
1ke5 | LS1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.479 | |
2r3j | SCJ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
3unj | 0BX | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.479 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
3py0 | SU9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.478 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.478 | |
4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.478 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.478 | |
4nak | PBQ | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase, chloroplastic | 2.7.7.60 | 0.478 | |
2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
3r28 | XA0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.477 | |
4fkp | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
4fv4 | EK7 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.477 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.477 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.477 | |
5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.477 | |
2b54 | D05 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.476 | |
2uzn | C96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.476 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
3krw | BA1 | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.476 | |
3pxy | JWS | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
3qtq | X35 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
3rai | X85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
4ix6 | ADP | Uncharacterized protein | / | 0.476 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.476 | |
5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.476 | |
5iu4 | ZMA | Adenosine receptor A2a | / | 0.476 | |
1snu | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.475 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.475 | |
2w1h | L0F | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.475 | |
3niz | ADP | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.475 | |
3t8o | ATP | Rhodopsin kinase | / | 0.475 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.475 | |
4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.475 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.475 | |
4o1p | ANP | Ribonuclease L | / | 0.475 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.475 | |
1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
1p2a | 5BN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.474 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.474 | |
2pau | D5M | 5'-deoxynucleotidase YfbR | / | 0.474 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
2r3o | 2SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.474 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.474 | |
4dpu | AGS | Mevalonate diphosphate decarboxylase | / | 0.474 | |
4wbo | ANW | Rhodopsin kinase | / | 0.474 | |
1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
2vuw | 5ID | Serine/threonine-protein kinase haspin | 2.7.11.1 | 0.473 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
2zv2 | 609 | Calcium/calmodulin-dependent protein kinase kinase 2 | 2.7.11.17 | 0.473 | |
3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.473 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
3o0g | 3O0 | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.473 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.473 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.473 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.473 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.472 | |
3qtx | X43 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.472 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.472 | |
4fv8 | E63 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.472 | |
4g6o | E28 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.472 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.472 | |
1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.471 | |
1p4f | DRG | Death-associated protein kinase 1 | 2.7.11.1 | 0.471 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.471 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.471 | |
3ibq | ATP | Pyridoxal kinase | / | 0.471 | |
3igg | EFQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
3uim | ANP | BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 | 2.7.10.1 | 0.471 | |
3vet | ADP | nebramycin 5' synthase | 6.1.2.2 | 0.471 | |
5dn3 | ATP | Aurora kinase A | 2.7.11.1 | 0.471 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.470 | |
2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
3ori | AGS | Serine/threonine protein kinase | / | 0.470 | |
3rpy | 27Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
3zze | 6XP | Hepatocyte growth factor receptor | 2.7.10.1 | 0.470 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.470 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.470 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
5auu | LU2 | Death-associated protein kinase 1 | 2.7.11.1 | 0.470 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.469 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
2emu | SAH | Diphthine synthase | / | 0.469 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.469 | |
3pj8 | 404 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.469 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.469 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.469 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.469 | |
4kd1 | 1QK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.469 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.468 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.468 | |
2c6l | DT4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.468 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.468 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.468 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.468 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.468 | |
4e93 | GUI | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.468 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.468 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.468 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
1m2q | MNX | Casein kinase II subunit alpha | 2.7.11.1 | 0.467 | |
2bhh | RYU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2jkq | VG8 | Focal adhesion kinase 1 | 2.7.10.2 | 0.467 | |
2ojg | 19A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.467 | |
2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.467 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
3blr | CPB | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.467 | |
3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.467 | |
3gga | GGW | Gag-Pol polyprotein | / | 0.467 | |
3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.467 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.467 | |
3rpo | 24Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
3sw7 | 19K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
3zc5 | W9Z | Hepatocyte growth factor receptor | 2.7.10.1 | 0.467 | |
3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.467 | |
4fkl | CK2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
4ix4 | ADP | Uncharacterized protein | / | 0.467 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.467 | |
1rx8 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.466 | |
2pmo | HMD | Protein kinase 7 | / | 0.466 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.466 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.466 | |
3owj | 1EL | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
3tku | M77 | Serine/threonine-protein kinase MRCK beta | 2.7.11.1 | 0.466 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.466 | |
4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
4eol | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.466 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.466 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
2gdo | 12C | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.465 | |
2vtr | LZB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
3zxz | KRW | Hepatocyte growth factor receptor | 2.7.10.1 | 0.465 | |
4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
4f09 | JAK | Tyrosine-protein kinase JAK2 | / | 0.465 | |
4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.465 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
2vtl | LZ5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.464 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.464 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.464 | |
3mpi | FAD | Glutaryl-CoA dehydrogenase | 1.3.99.32 | 0.464 | |
3pd2 | A3S | Threonine--tRNA ligase | 6.1.1.3 | 0.464 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.464 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.464 | |
1h0v | UN4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.463 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
2pzi | AXX | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.463 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.463 | |
3a7j | ADP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.463 | |
3oib | FDA | Putative acyl-CoA dehydrogenase | / | 0.463 | |
4ap7 | F47 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.463 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.463 | |
4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.463 | |
4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.463 | |
4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.463 | |
4y3j | HIC | Endothiapepsin | 3.4.23.22 | 0.463 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.462 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.462 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
3c4z | ADP | Rhodopsin kinase | / | 0.462 | |
3wb2 | YGP | Uncharacterized protein MJ0488 | / | 0.462 | |
4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.462 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
4fyo | 0VF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.462 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.462 | |
4yd7 | F5N | Endothiapepsin | 3.4.23.22 | 0.462 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.462 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
2x2m | X2M | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.461 | |
3qtr | X36 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3qwk | X62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
3r1y | X76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
4bis | 8HQ | Lysine-specific demethylase 4A | 1.14.11 | 0.461 | |
4deg | 0JJ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.461 | |
4e6q | 0NV | Tyrosine-protein kinase JAK2 | / | 0.461 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.461 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.461 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
3b89 | 5GP | 16S rRNA methylase | / | 0.460 | |
3f88 | 3HT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
3kga | LX9 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.460 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
3r83 | Z14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
3vf8 | 0JE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.460 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.460 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.460 | |
4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.459 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.459 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.459 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
3qqh | X0A | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.459 | |
3zlx | 5EZ | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.459 | |
4fki | 09K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.458 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.458 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.458 | |
2vto | LZ8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
3c50 | ADP | Rhodopsin kinase | / | 0.458 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.458 | |
4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.458 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.458 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
1dm2 | HMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
1gvt | 2ZS | Endothiapepsin | 3.4.23.22 | 0.457 | |
1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.457 | |
1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.457 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.457 | |
2etk | HFS | Rho-associated protein kinase 1 | 2.7.11.1 | 0.457 | |
3jpv | 1DR | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.457 | |
3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.457 | |
4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.457 | |
4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.457 | |
4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.457 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
4gu6 | 10N | Focal adhesion kinase 1 | 2.7.10.2 | 0.457 | |
4rcv | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.457 | |
1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.456 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.456 | |
2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.456 | |
2jkk | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.456 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
3nd1 | SAH | Precorrin-6A synthase (Deacetylating) | / | 0.456 | |
3ql8 | X01 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.456 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
4n57 | ADP | APH(2'')-Id | / | 0.456 | |
4y95 | 746 | Tyrosine-protein kinase | / | 0.456 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.456 | |
1lp4 | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.455 | |
1ppm | 0P1 | Penicillopepsin-1 | 3.4.23.20 | 0.455 | |
1sxj | AGS | Replication factor C subunit 1 | / | 0.455 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
2hux | SAH | Diphthine synthase | / | 0.455 | |
2pmn | K51 | Protein kinase 7 | / | 0.455 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
3img | BZ2 | Pantothenate synthetase | 6.3.2.1 | 0.455 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
3ncz | 3NC | Rho-associated protein kinase 1 | 2.7.11.1 | 0.455 | |
3t7x | 4SH | Endothiapepsin | 3.4.23.22 | 0.455 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.455 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.455 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
4ckj | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.455 | |
4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.455 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.455 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.455 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.455 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
4u0m | GTP | Cyclic GMP-AMP synthase | / | 0.455 | |
5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.455 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.455 | |
1lm1 | FMN | Ferredoxin-dependent glutamate synthase 2 | 1.4.7.1 | 0.454 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
1w8c | N69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.454 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
2oji | 33A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
2v00 | V15 | Endothiapepsin | 3.4.23.22 | 0.454 | |
2w9h | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
3t8v | BTJ | M1 family aminopeptidase | 3.4.11 | 0.454 | |
3v9y | 24L | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.454 | |
4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.454 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
4jin | 1L7 | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.454 | |
5iub | CLR | Adenosine receptor A2a | / | 0.454 | |
1wng | SAH | Diphthine synthase | / | 0.453 | |
1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.453 | |
2azz | TCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.453 | |
2eka | SAH | Diphthine synthase | / | 0.453 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.453 | |
2fum | MIX | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.453 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.453 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.453 | |
2r3p | 3SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
3ime | BZ2 | Pantothenate synthetase | 6.3.2.1 | 0.453 | |
3qx4 | X4B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
3sf6 | FDA | Glutaryl-CoA dehydrogenase | / | 0.453 | |
3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
3v3v | MYU | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.453 | |
3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.453 | |
4bzn | UGX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.453 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.453 | |
1qiw | DPD | Calmodulin | / | 0.452 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.452 | |
1xel | UPG | UDP-glucose 4-epimerase | 5.1.3.2 | 0.452 | |
2b7z | MK1 | Gag-Pol polyprotein | / | 0.452 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
2v4l | ABJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
3a4v | NAD | NDP-sugar epimerase | / | 0.452 | |
3kjm | 245 | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.452 | |
3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.452 | |
4du8 | 2P0 | Mevalonate diphosphate decarboxylase | / | 0.452 | |
4gur | FAD | Lysine-specific histone demethylase 1B | 1 | 0.452 | |
4ijp | 1EH | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.452 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
4lfi | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
4o4f | ATP | Kinase | / | 0.452 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.452 | |
4z63 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.452 | |
1hsh | MK1 | Gag-Pol polyprotein | / | 0.451 | |
1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
1uy7 | PU4 | Heat shock protein HSP 90-alpha | / | 0.451 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.451 | |
2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.451 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.451 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.451 | |
3img | BZ3 | Pantothenate synthetase | 6.3.2.1 | 0.451 | |
3r8u | Z31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.451 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
4an9 | 2P7 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.451 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.451 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4ifc | ADP | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.451 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.451 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.451 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.451 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.451 | |
1b38 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
1kc1 | NDP | dTDP-4-dehydrorhamnose reductase | 1.1.1.133 | 0.450 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
1xl5 | 190 | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
2fy4 | COA | Choline O-acetyltransferase | 2.3.1.6 | 0.450 | |
3at3 | ATK | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.450 | |
3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.450 | |
3pvu | QRW | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.450 | |
3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
3r8p | Z46 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.450 | |
4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
4h4q | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.450 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
4o4e | ATP | Kinase | / | 0.450 | |
4oti | MI1 | Serine/threonine-protein kinase N1 | / | 0.450 | |
1e8x | ATP | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
1zao | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.449 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
2owu | SAH | Diphthine synthase | / | 0.449 | |
2qbl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.449 | |
3dpd | 41A | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.449 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.449 | |
5ani | ES4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.448 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
1vik | BAY | Gag-Pol polyprotein | / | 0.448 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.448 | |
2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.448 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
2pb4 | SAH | Diphthine synthase | / | 0.448 | |
2pwc | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
3ggg | NAD | Prephenate dehydrogenase | / | 0.448 | |
3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.448 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.448 | |
3t4n | ADP | 5'-AMP-activated protein kinase subunit gamma | / | 0.448 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.448 | |
4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.448 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.448 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.448 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.448 | |
4nmb | FAD | Bifunctional protein PutA | / | 0.448 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.448 | |
5fwn | NAP | Putative dehydrogenase | / | 0.448 | |
1v9a | SAH | Uncharacterized protein | / | 0.447 | |
1y7u | COA | Acyl-CoA hydrolase | / | 0.447 | |
1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.447 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.447 | |
2e9p | 77A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2oj9 | BMI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.447 | |
2pvm | P29 | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.447 | |
3cxw | 7CP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
3lsi | FAD | Pyranose 2-oxidase | / | 0.447 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.447 | |
3qih | FG7 | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
3r6s | CMP | CRP-like cAMP-activated global transcriptional regulator | / | 0.447 | |
3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3zpt | M8Y | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
4btm | F8E | Tau-tubulin kinase 1 | 2.7.11.1 | 0.447 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.447 | |
4iql | FMN | Enoyl-(Acyl-carrier-protein) reductase II | / | 0.447 | |
4j54 | G52 | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.447 | |
4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.447 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.447 | |
4z61 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.447 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
1day | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.446 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.446 | |
1t88 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
2hl2 | SSA | Threonine--tRNA ligase | 6.1.1.3 | 0.446 | |
2xiy | XIY | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.446 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.446 | |
3h9f | 92M | Dual specificity protein kinase TTK | 2.7.12.1 | 0.446 | |
3m42 | HGF | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.446 | |
3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.446 | |
3orp | AGS | Serine/threonine protein kinase | / | 0.446 | |
3u9e | COA | Lmo1369 protein | / | 0.446 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.446 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.446 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.446 | |
4wh3 | ATP | N-acetylhexosamine 1-kinase | 2.7.1.162 | 0.446 | |
1b39 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
1c70 | L75 | Protease | / | 0.445 | |
1gvv | 0GM | Endothiapepsin | 3.4.23.22 | 0.445 | |
1h1p | CMG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.445 | |
1orr | NAD | CDP-paratose 2-epimerase | / | 0.445 | |
1v0o | INR | Cell division control protein 2 homolog | 2.7.11.22 | 0.445 | |
2ccu | 2D9 | Heat shock protein HSP 90-alpha | / | 0.445 | |
2e8h | SAH | Diphthine synthase | / | 0.445 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
2p5u | NAD | UDP-glucose 4-epimerase | / | 0.445 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
2xvu | 9DN | Serum albumin | / | 0.445 | |
2yer | TQ1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.445 | |
3ea4 | FAB | Acetolactate synthase, chloroplastic | 2.2.1.6 | 0.445 | |
3el5 | 1UN | Gag-Pol polyprotein | / | 0.445 | |
3pjc | PJC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.445 | |
4a9u | A9U | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.445 | |
4gg5 | 0J3 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.445 | |
4im0 | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.445 | |
4l49 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.445 | |
4xx0 | COA | Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial | 6.2.1.4 | 0.445 | |
1ia1 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
1phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.444 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.444 | |
2dv7 | SAH | Diphthine synthase | / | 0.444 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.444 | |
2jam | J60 | Calcium/calmodulin-dependent protein kinase type 1G | 2.7.11.17 | 0.444 | |
2wkm | PFY | Hepatocyte growth factor receptor | 2.7.10.1 | 0.444 | |
2wyv | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.444 | |
2xj1 | XJ1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
3dv3 | MEK | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.444 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.444 | |
3q9z | TXQ | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
3qf9 | NM8 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3tea | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.444 | |
4hj6 | FMN | LOV protein | / | 0.444 | |
4j5j | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
4l4c | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.444 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.444 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.444 | |
1c6x | 3IN | Protease | / | 0.443 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
1omo | NAD | Alanine dehydrogenase | / | 0.443 | |
1xdd | AAY | Integrin alpha-L | / | 0.443 | |
1zp9 | ATP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.443 | |
2b55 | D31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.443 | |
2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
2ym8 | YM8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.443 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.443 | |
3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.443 | |
3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.443 | |
3q92 | XNB | Ketohexokinase | / | 0.443 | |
3rq6 | APR | ADP-dependent (S)-NAD(P)H-hydrate dehydratase | / | 0.443 | |
3so9 | 017 | Pol protein | / | 0.443 | |
3srs | M23 | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.443 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
4ev0 | CMP | Cyclic AMP receptor protein | / | 0.443 | |
4f9m | FCM | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.443 | |
4lrj | ANP | Uncharacterized protein | / | 0.443 | |
4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.443 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.443 | |
4xf7 | ACP | Carbohydrate/pyrimidine kinase, PfkB family | / | 0.443 | |
4y4j | LNR | Endothiapepsin | 3.4.23.22 | 0.443 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.443 | |
1ay0 | TPP | Transketolase 1 | 2.2.1.1 | 0.442 | |
1bws | NDP | GDP-L-fucose synthase | / | 0.442 | |
1e82 | M90 | Endothiapepsin | 3.4.23.22 | 0.442 | |
1gth | FAD | Dihydropyrimidine dehydrogenase [NADP(+)] | 1.3.1.2 | 0.442 | |
1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
1t85 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
1tqm | ANP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.442 | |
2b53 | D23 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2bhe | BRY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2ed5 | SAH | Diphthine synthase | / | 0.442 | |
2gtn | LIE | Mitogen-activated protein kinase 14 | / | 0.442 | |
2h94 | FAD | Lysine-specific histone demethylase 1A | 1 | 0.442 | |
2ieo | 017 | Protease | / | 0.442 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.442 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
3cgc | COA | Coenzyme A disulfide reductase | / | 0.442 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.442 | |
3fr8 | NDP | Ketol-acid reductoisomerase, chloroplastic | 1.1.1.86 | 0.442 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.442 | |
3qa2 | XNA | Ketohexokinase | / | 0.442 | |
3qzi | X72 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3tiz | 3TI | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4g3f | 0WB | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.442 | |
4jb1 | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.442 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.442 | |
4r3a | RBF | Blue-light-activated histidine kinase 2 | 2.7.13.3 | 0.442 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.442 | |
5k2b | ZMA | Adenosine receptor A2a | / | 0.442 | |
1dr3 | HBI | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
2c6m | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.441 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
2nni | MTK | Cytochrome P450 2C8 | / | 0.441 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
3cd5 | 7HI | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.441 | |
3fws | ANP | Transcriptional repressor CcpN | / | 0.441 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
3iod | A6D | Pantothenate synthetase | 6.3.2.1 | 0.441 | |
3ka0 | MK3 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.441 | |
3qql | X03 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3qzf | X66 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
3tm0 | ANP | Aminoglycoside 3'-phosphotransferase | 2.7.1.95 | 0.441 | |
4k5o | 1OT | M1 family aminopeptidase | 3.4.11 | 0.441 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.441 | |
4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.441 | |
4y9q | C2E | Uncharacterized protein | / | 0.441 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
1ci7 | UMP | Thymidylate synthase | 2.1.1.45 | 0.440 | |
1e80 | 0GQ | Endothiapepsin | 3.4.23.22 | 0.440 | |
1msm | JE2 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
1nhh | ANP | DNA mismatch repair protein MutL | / | 0.440 | |
1qrp | HH0 | Pepsin A-4 | 3.4.23.1 | 0.440 | |
1u8v | FAD | 4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA-Delta-isomerase | / | 0.440 | |
2hl1 | A3S | Threonine--tRNA ligase | 6.1.1.3 | 0.440 | |
2xlr | FAD | Putative flavin-containing monooxygenase | / | 0.440 | |
3g5q | FAD | Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO | / | 0.440 | |
3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.440 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.440 | |
3lf0 | ATP | Nitrogen regulatory protein P-II | / | 0.440 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
3r7u | X96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3rzb | 02Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3uic | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.440 | |
4a4l | 939 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.440 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.440 | |
4anb | YQY | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.440 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4g73 | NAI | Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial | 1.6.5.9 | 0.440 | |
4k28 | NAD | Shikimate dehydrogenase family protein | / | 0.440 | |
4l4b | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
5av0 | 47X | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 |